Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
Development and prospective validation of a pathology-based AI model to predict the time to castration resistance in prostate cancer.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan [Phase 4]
Phase 4 clinical trial pilot evaluating 18F-DCFPyL-PSMA PET imaging in men with metastatic castration-resistant prostate cancer who are rece…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy [Phase 2]
Phase 2 clinical trial update evaluating multiparametric MRI to assess treatment response after prostate radiotherapy.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation [Phase 2]
A Phase 2 clinical trial is evaluating carboplatin chemotherapy before surgery in men with high-risk prostate cancer who carry BRCA1 or BRCA…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: The Development and Validation of MRI-AI-based Predictive Models for csPCa
A clinical trial is developing and validating MRI-based AI models to predict clinically significant prostate cancer. The study is currently …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: LDR vs. HDR Brachytherapy for Prostate Cancer [NA]
A clinical trial update notes an active not recruiting study comparing low-dose-rate (LDR) versus high-dose-rate (HDR) brachytherapy for pro…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy [NA]
This ClinicalTrials.gov update describes a study comparing high-dose-rate and low-dose-rate brachytherapy for prostate cancer and its impact…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Two Fraction Prostate SBRT With DIL SIB [Phase 1]
A Phase 1 trial from NYU Langone Health is testing two-fraction prostate SBRT with a dominant intraprostatic lesion (DIL) simultaneous integ…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating whether adding androgen deprivation therapy (ADT) to SBRT improves outcomes versus SBRT alone in unfavorab…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating talazoparib in combination with androgen deprivation therapy and abiraterone for castration-sensitive pros…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy [NA]
City of Hope Medical Center is recruiting a study to test whether oral cryotherapy can reduce taste changes in prostate cancer patients rece…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R) [Phase 2]
Phase II non-randomized trial evaluating POSLUMA-PSMA PET response after radiotherapy-directed treatment in oligometastatic or progressive p…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa
This clinical trial update describes a study investigating heterogeneity in hormone therapy response to identify early determinants of drug …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of vorinostat and Lutetium-177 PSMA-617 for PSMA-low metastatic castration-resistant pro…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial at University of Wisconsin–Madison evaluating androgen deprivation with or without pTVG-AR and with or without T-…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE) [Phase 3]
Phase 3 trial ASPIRE is evaluating adaptive SBRT for localized prostate cancer versus image-guided radiotherapy; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.
This clinical trial investigates using Lutetium-177 dosimetry as a predictive biomarker of response for metastatic prostate cancer patients …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer. [NA]
A clinical trial evaluating UroLift before SBRT to reduce urinary toxicity in patients with benign prostatic hyperplasia and prostate cancer…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness [Phase 1, Phase 2]
An ongoing Phase 1/2 trial from University of Maryland examining how androgen deprivation therapy interacts with circadian rhythm and physio…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: The SUGAR Study; SBRT and Relugolix) for Prostate Cancer [Phase 2]
A Phase 2 clinical trial at Yale University is evaluating the combination of SBRT and Relugolix for prostate cancer and is currently recruit…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate Cancer [NA]
A clinical trial update evaluating imaging characteristics of different Gallium-68 PSMA PET probes in prostate cancer. The study status is n…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating PSMA PET/MR-guided SBRT with simultaneous integrated boost for high-intermediate and high-risk prostate cancer is c…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer [Phase 1]
Phase 1 trial evaluating Xaluritamig in high-risk biochemically recurrent, non-metastatic castration-sensitive prostate cancer (Amgen-sponso…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating cabozantinib in combination with nivolumab for metastatic castration-resistant prostate cancer is curren…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations [Phase 2]
Phase 2 study evaluating neoadjuvant PARP inhibition followed by radical prostatectomy in men with unfavorable intermediate- or high-risk pr…